• Return to Headlines

31.3% Return Seen to Date on SmarTrend Concert Pharmace Call (CNCE)

By James Quinn

SmarTrend identified a Downtrend for Concert Pharmace (NASDAQ:CNCE) on April 6th, 2018 at $19.33. In approximately 5 months, Concert Pharmace has returned 31.30% as of today's recent price of $13.28.

Over the past year, Concert Pharmacehas traded in a range of $13.23 to $30.71 and are now at $13.29. In the last five trading sessions, the 50-day moving average (MA) has fallen 1.5% while the 200-day MA has slid 0.8%.

Concert Pharmaceuticals, Inc. is a clinical stage biotechnology company. The Company focuses on the use of deuterium to enhance the effects of approved drugs. Concert Pharmaceuticals offers its products throughout the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Concert Pharmace.

Log in and add Concert Pharmace (CNCE) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights concert pharmace

Ticker(s): CNCE